INCARDA THERAPEUTICS
InCarda Therapeutics is a clinical-stage drug delivery company pioneering a novel approach of treating acute cardiovascular diseases/conditions by the inhalation route. Lead product is InRhythm, an inhaled formulation of an antiarrhythmic drug to treat acute paroxysmal atrial fibrillation events within minutes at home, at work, or anywhere. Completed Phase 1 and currently advancing lead product through Phase 2. InCarda Therapeutics was founded in Newark, California.
INCARDA THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2009-01-01
Address:
Newark, California, United States
Country:
United States
Website Url:
http://www.incardatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 510 422 5522
Email Addresses:
[email protected]
Total Funding:
77.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series C - InCarda Therapeutics
HealthCap
HealthCap investment in Series C - InCarda Therapeutics
Innoviva
Innoviva investment in Series C - InCarda Therapeutics
Deerfield
Deerfield investment in Series C - InCarda Therapeutics
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series B - InCarda Therapeutics
Deerfield
Deerfield investment in Series B - InCarda Therapeutics
Morningside Ventures
Morningside Ventures investment in Series B - InCarda Therapeutics
HealthCap
HealthCap investment in Series B - InCarda Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series B - InCarda Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Venture Round - InCarda Therapeutics
Official Site Inspections
http://www.incardatherapeutics.com
- Host name: 251.69.197.104.bc.googleusercontent.com
- IP address: 104.197.69.251
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
